Stay updated on Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial

Sign up to get notified when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Study Documents now lists Revision 3.4.2 for the protocol and related documents, replacing Revision 3.4.1.
    Difference
    0.0%
    Check dated 2026-02-12T02:24:08.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:30:53.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Additions include a glossary display toggle and new metadata items such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T21:46:59.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.3.4 now appears on the page, replacing v3.3.3, representing a backend/version update with no impact on study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:30:36.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Consolidated the Location listings into a single Locations section listing CT, GA, MD, MA, NY, NC, PA, and TN, and updated the page revision to v3.3.3. The previous per-state 'Locations' headings (CT, GA, MD, MA, NY, NC, PA, TN) were removed, and the HHS Vulnerability Disclosure note was deleted.
    Difference
    0.7%
    Check dated 2025-12-23T20:50:56.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    The Publications section now clarifies that publications are automatically filled from PubMed, and the revision version has been updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:55:12.000Z thumbnail image

Stay in the know with updates to Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.